SIGA - SIGA Technologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
4.50
+0.10 (+2.27%)
At close: 1:45PM EST
Stock chart is not supported by your current browser
Previous Close4.40
Open4.47
Bid0.00 x 0
Ask0.00 x 0
Day's Range4.32 - 4.60
52 Week Range2.34 - 5.24
Volume7,625
Avg. Volume53,412
Market Cap355.09M
Beta1.76
PE Ratio (TTM)N/A
EPS (TTM)-0.51
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.00
Trade prices are not sourced from all markets
  • GlobeNewswire2 months ago

    SIGA to Present at the Cantor Fitzgerald Global Healthcare Conference on September 27, 2017

    NEW YORK, Sept. 20, 2017-- SIGA Technologies, Inc., a company specializing in the development and commercialization of solutions for serious unmet medical needs and biothreats, today announced that Dr. ...

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
    Capital Cube3 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017

    Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017
    Capital Cube5 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 9, 2017

    Categories: Yahoo FinanceGet free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc. and Newlink Genetics Corporation (ACHN-US, ... Read more (Read more...)

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube8 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc., Newlink Genetics Corporation and NanoViricides, ... Read more (Read more...)

  • SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
    Capital Cube8 months ago

    SIGA Technologies, Inc. :SIGA-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017

    Categories: Yahoo Finance Get free summary analysis SIGA Technologies, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of SIGA Technologies, Inc. – Achillion Pharmaceuticals, Inc., Emergent BioSolutions Inc., SciClone Pharmaceuticals, Inc., Novavax, Inc., Sarepta Therapeutics, Inc., Chimerix, Inc., BioCryst Pharmaceuticals, Inc., Newlink Genetics Corporation and NanoViricides, ... Read more (Read more...)

  • TheStreet.comlast year

    PharmAthene Declares Special Cash Dividend

    The biodefense company on Thursday declared a special one-time cash dividend, a day after receiving final payment from Siga in connection with a drug license dispute.